StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Acadia Pharmaceuticals (ACAD) PT Lowered to $28 at Baird
May 9, 2024 6:21 AM
(Updated - May 9, 2024 6:30 AM EDT)
Baird analyst Joel Beatty lowered the price target on Acadia Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Acadia Pharmaceuticals (ACAD) PT Lowered to $22 at BofA Securities
May 10, 2024 5:24 AM